Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

In light of intermittent supply shortages of individual vaccines and evidence of rare but serious adverse events after vaccination, heterologous regimens for COVID-19 vaccines have gained significant interest. This study aims to assess the reactogenicity and immunogenicity of the heterologous adenov...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nasamon Wanlapakorn, Nungruthai Suntronwong, Harit Phowatthanasathian, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Chompoonut Auphimai, Donchida Srimuan, Thaksaporn Thatsanatorn, Suvichada Assawakosri, Sitthichai Kanokudom, Yong Poovorawan
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2022-01-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	heterologous homologous inactivated covid-19 vaccine viral vectored adults
Accés en línia:	http://dx.doi.org/10.1080/21645515.2022.2029111
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!